Retrospective cohort study of Huashi Baidu granules in the treatment of mild COVID-19
Phase 4
- Conditions
- ovel Coronavirus Pneumonia (COVID-19)
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
It conforms to the mild diagnosis of COVID-19 in the Novel Coronavirus Diagnosis and Treatment Protocol for Pneumonia Infection (Trial Version 9) released by the National Health Commission. The novel Coronavirus nucleic acid test confirmed the mild clinical symptoms, including low fever, slight fatigue, olfactory and gustatory impairment.
Exclusion Criteria
Asymptomatic infected persons; Patients with serious primary diseases of cardio-cerebrovascular, lung, kidney and hematopoietic system; Pregnant or lactating women; History of allergy to prescribed drugs.
Study & Design
- Study Type
- Observational study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time of first negative nucleic acid conversion;length of hospitalization;
- Secondary Outcome Measures
Name Time Method